10x Genomics: Q2 Earnings Snapshot
PLEASANTON, Calif. (AP) _ 10x Genomics Inc. (TXG) on Monday reported a loss of $64.5 million in its second quarter.
On a per-share basis, the Pleasanton, California-based company said it had a loss of 57 cents.
The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share.
The life science technology company posted revenue of $114.6 million in the period.
10x Genomics expects full-year revenue in the range of $500 million to $520 million.